Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Genetic Skin Disease in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
Hospital ASEPEYO Sant Cugat
Nacuity Pharmaceuticals, Inc.
iCAD
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Korean Society of Spine Surgery
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Alma Lasers Inc.
Apollo Neuroscience, Inc.
Eurofins Genoma
Aptis Medical
Hospital Durand, Argentina
Agency for Science, Technology and Research
Everett Meyer
Mª Victoria Maestre Sanchez
Neurophth Therapeutics Inc
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Kupfer, David J., M.D.
GFI
ASST Cremona, Cremona
RMIT University, Melbourne, Australia
View Full List
Medical Conditions
RISS Stage III Plasma Cell Myeloma
Corneal Cross-Linking
Chronic Constipation Symptoms
Immune-Mediated Inflammatory Disease
Treatment Decisions
Disorder of Fluid Balance
Rheumatoid Arthritis(RA)
Recurrent Clear Cell Sarcoma of Soft Tissue
Fever
Dienogest
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Metachronous Adenoma
Scleredema
The Strength Properties of the Aorta in Vitro
T-LGL Leukemia
Luteal Phase Support
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Major Liver Surgery
Splenic Trauma
Gastric Cancer Stage IIIB-IIIC
View Full List
Drug Interventions
Capecitabine/cisplatin
Midazolam
RDX227675
Fospropofol disodium, propofol
TPN-101
Standard of care (SOC) for COVID-19
Intravenous Formulation of PD-0332991
PD-1/PD-L1 inhibitor
Olopatadine
Intravenous deferiprone
Letrozole
Desvenlafaxine
GLPG1837 multiple ascending doses
OnabotulinumtoxinA
Capecitabine and IMRT (if randomized to this arm)
Camptosar
THC
Anticholinergic
MLN2480
Oxycodone/acetaminophen 5/325 mg
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Belgium
Contract Research Organizations in Benin
Contract Research Organizations in Djibouti
Contract Research Organizations in France
Contract Research Organizations in India
Contract Research Organizations in Lithuania
Contract Research Organizations in Oman
Contract Research Organizations in Panama
Contract Research Organizations in Paraguay
Contract Research Organizations in Spain
Contract Research Organizations in Tanzania
Contract Research Organizations in Uganda
CRO list by country
CROs in Bahrain
SGS
All CROs in Bahrain
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe